Awakn Life Sciences (TSE:AWKN) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Awakn Life Sciences Corp., a biotech firm advancing treatments for substance use and mental health disorders, has announced a collaboration with Graft Polymer to enhance its trauma-focused Aminoindane NCEs program. This partnership aims to speed up the development of new therapies for mental health conditions like PTSD, leveraging Graft’s drug delivery systems and both companies’ shared expertise and financial investment.
For further insights into TSE:AWKN stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue